FDA Approves Pancreatic Cancer Drug Rasonque
The FDA approved Rasonque for national use. A clinical trial showed the drug nearly doubled overall survival. This benefit is based on a single study. Real-world effectiveness and long-term outcomes are not yet known.
Why it matters
This offers a new treatment option for a disease with limited survival prospects after a trial showed significant life extension.
CHECKED · 1 SOURCE · UNCORROBORATED
← All news